That similar pathologies were not observed with either AMPK-α1 or AMPK-α2 deletion alone is also important, because this suggests redundancy of function that might afford new AMPK isoform- and thus pulmonary-selective therapeutic strategies against PPHN. This evidence concerns the gene PRKAA1 and persistent fetal circulation syndrome.